Dominique TrudelM.D., Ph.D., FRCPC

Trinh VQ, Benzerdjeb N, Chagnon-Monarque S, Dionne N, Delouya G, Kougioumoutzakis A, Sirois J, Albadine R, Latour M, Mes-Masson AM, Hovington H, Bergeron A, Zorn KC, Fradet Y, Saad F, Taussky D, Trudel D

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate.

Radiat Oncol, 14 (1), p. 60, 2019.

Résumé | Liens:

Wissing M, Brimo F, Chevalier S, Scarlata E, McKercher G, O'Flaherty A, Aprikian S, Thibodeau V, Saad F, Carmel M, Lacombe L, Tetu B, Ekindi-Ndongo N, Latour M, Trudel D, Aprikian A

Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.

BJU Int, 123 (4), p. 624-631, 2019, ISSN: 1464-4096.

Résumé | Liens:

Trudel D, Avarvarei LM, Orain M, Turcotte S, Plante M, Gregoire J, Kappelhoff R, Labbe DP, Bachvarov D, Tetu B, Overall CM, Bairati I

Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer.

Pathol Res Pract, 2019, ISSN: 0344-0338.

Résumé | Liens:

Pinto M, Zorn KC, Tremblay JP, Desroches J, Dallaire F, Aubertin K, Marple E, Kent C, Leblond F, Trudel D, Lesage F

Integration of a Raman spectroscopy system to a robotic-assisted surgical system for real-time tissue characterization during radical prostatectomy procedures.

J Biomed Opt, 24 (2), p. 1-10, 2019, ISSN: 1083-3668.

Résumé | Liens:

Gaudreau PO, Clairefond S, Class CA, Boulay PL, Chrobak P, Allard B, Azzi F, Pommey S, Do KA, Saad F, Trudel D, Young M, Stagg J

WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors.

Oncoimmunology, 8 (5), p. e1581545, 2019, ISSN: 2162-4011.

Résumé | Liens:

Sharma NV, Pellegrini KL, Ouellet V, Giuste FO, Ramalingam S, Watanabe K, Adam-Granger E, Fossouo L, You S, Freeman MR, Vertino P, Conneely K, Osunkoya AO, Trudel D, Mes-Masson AM, Petros JA, Saad F, Moreno CS

Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer.

Cancers (Basel), 10 (10), 2018, ISSN: 2072-6694.

Résumé | Liens:

Gagne A, Tetu B, Orain M, Turcotte S, Plante M, Gregoire J, Renaud MC, Bairati I, Trudel D

Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.

Diagn Pathol, 13 (1), p. 75, 2018.

Résumé | Liens:

Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L, Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf JB, van der Kwast T, Squire JA, Latour M, Trudel D, Mes-Masson AM, Saad F

The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.

BMC Urol, 18 (1), p. 78, 2018.

Résumé | Liens:

Leyh-Bannurah SR, Trudel D, Latour M, Zaffuto E, Grosset AA, Tam C, Ouellet V, Graefen M, Budaus L, Aprikian AG, Lacombe L, Fleshner NE, Gleave ME, Mes-Masson AM, Saad F, Karakiewicz PI

A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.

Pathol Oncol Res, 2018, ISSN: 1219-4956.

Résumé | Liens:

Desroches J, Jermyn M, Pinto M, Picot F, Tremblay MA, Obaid S, Marple E, Urmey K, Trudel D, Soulez G, Guiot MC, Wilson BC, Petrecca K, Leblond F

A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy.

Sci Rep, 8 (1), p. 1792, 2018, ISSN: 2045-2322.

Résumé | Liens: